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Background: A few lineages of Group A streptococci (GAS) have been associated with a reemergence of severe
invasive streptococcal disease in developed countries. However, the majority of the comparisons between invasive
and non-invasive GAS isolates have been performed for collections of reduced genetic diversity or relied on limited
typing information to distinguish clones. We characterized by several typing methods and compared a collection of
160 isolates recovered from normally sterile sites with 320 isolates associated with pharyngitis and recovered in the
same time period in Portugal.
Results: Although most of the isolates belonged to clones that were equally prevalent in invasive infections and
pharyngitis, we identified markers of invasiveness, namely the emm types 1 and 64, and the presence of the speA
and speJ genes. In contrast, emm4, emm75, and the ssa and speL/M genes were significantly associated with
pharyngitis. There was a strong agreement between the emm type, the superantigen (SAg) genes and the clusters
defined by pulsed-field gel electrophoresis (PFGE) profiling. Therefore, combinations of particular emm types and
SAg genes frequently co-occurred in the same PFGE cluster, but there was no synergistic or antagonistic interaction
between them in determining invasiveness. Only macrolide-susceptible PFGE clones were significantly associated
with invasive infections or pharyngitis, while the clones of resistant isolates sharing all other molecular properties
analyzed were equally prevalent in the two groups of isolates.
Conclusions: This study confirmed the importance of the widely disseminated emm1-T1-ST28 clone in invasive
infections but also identified other clones linked to either invasive infections (emm64-ST164) or pharyngitis
(emm4-T4-ST39), which may be more limited in their temporal and geographical spread. Clonal properties like
some emm types or SAg genes were associated with disease presentation, highlighting the importance of bacterial
genetic factors to the outcome of GAS infections, although other, yet unidentified factors may also play an
important role.
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Streptococcus pyogenes (Lancefield group A Streptococcus,
GAS) remains one of the most common human patho-
gens, being responsible for uncomplicated superficial
infections of the respiratory tract and skin, such as
tonsillo-pharyngitis and impetigo, but also causing se-
vere and rapidly progressing invasive disease such as
necrotizing fasciitis, bacteremia, streptococcal toxic
shock syndrome (STSS), puerperal sepsis, pneumonia,
and meningitis [1]. Although the incidence and severity
of GAS infections in industrialized countries decreased
for most of the 20th century, a reemerge of GAS invasive
disease has been noted since the late 1980s, both in
North America and in Europe [2]. The annual incidence of
GAS invasive disease has been estimated at 2.45/100 000
for developed countries, with a median case fatality rate of
15% [3].
The increase in the incidence of GAS invasive infec-
tions has been frequently associated with specific clones,
raising the possibility that the rise of particularly virulent
clones was responsible for this reemergence, in particu-
lar the M1T1 clone which is dominant among invasive
GAS isolates in most developed countries [4,5]. How-
ever, a higher representation of a particular clone in in-
vasive infections may be simply due to a high prevalence
of that same clone in the general GAS population. To
address this question several studies have performed
comparisons between the characteristics of the invasive
clones and the S. pyogenes isolates associated with car-
riage or uncomplicated infections in the same time
period and geographic region. Some of those studies
reported a differential distribution of M/emm types or of
T types between invasive and non-invasive isolates and
confirmed an association between serotype T1 and M1/
emm1 and invasive infection [6-9], but many others
found that the major clones responsible for invasive
infections had a similar prevalence among non-invasive
infections [10-12]. However, most of the studies per-
forming such comparisons were either restricted to
small numbers of isolates or were limited in the typing
methodologies used, relying essentially on M/emm
typing.
Serotyping of GAS based on protein M, a major sur-
face virulence factor, has long been used as the gold
standard for the epidemiological surveillance of the
infections caused by this pathogen. In recent years it has
been widely replaced by an equivalent approach based
on sequencing the hypervariable region of the emm gene
encoding the M protein. However, recent studies show
that emm typing alone is not sufficient to unambigu-
ously identify GAS clones and that it must be comple-
mented with other typing methods such as pulsed-field
gel electrophoresis (PFGE) macrorestriction profiling or
multilocus sequence typing (MLST) [13]. Streptococcalsuperantigens (SAgs) secreted by S. pyogenes play an im-
portant role in the pathogenesis of the infections caused
by this species [14]. The profiling of the eleven SAg
genes described so far (speA, speC, speG, speH, speI, speJ,
speK, speL, speM, ssa, smeZ) can be used as a typing
methodology [15]. Some studies suggested an association
between the presence of certain SAg genes or of certain
SAg gene profiles and invasive infections [10,16], al-
though others failed to establish such an association,
reporting instead a strong link between the SAg profile
and the emm type, regardless of the isolation site
[12,15].
We have previously characterized a collection of 160
invasive GAS isolates collected throughout Portugal be-
tween 2000 and 2005, and found a very high genetic di-
versity among this collection, but with a dominant clone
representing more than 20% of the isolates, which was
characterized as emm1-T1-ST28 and carried the gene
speA [17]. The aim of the present study was to evaluate
if the clone distribution among the invasive GAS isolates
in Portugal reflected the clonal structure of the isolates
causing pharyngitis, in terms of molecular properties
and antimicrobial resistance. In order to do that, 320
non-duplicate isolates collected from pharyngeal exu-
dates associated with tonsillo-pharyngitis in the same
time period were studied by emm typing, T typing, SAg
profiling, PFGE macrorestriction profiling, and selected
isolates were also submitted to MLST analysis. All iso-
lates were also tested for their susceptibility to clinically
and epidemiologically relevant antimicrobial agents. The
great majority of the clones were found with a similar
frequency among invasive infections and pharyngitis.
Still, some clones were shown to have a higher invasive
disease potential and it was also possible to establish sig-
nificant associations between some emm types and SAg
genes and disease presentation.
Results
Antimicrobial resistance
All isolates were fully susceptible to penicillin, quinupristin/
dalfopristin, chloramphenicol, vancomycin, linezolid, and
levofloxacin (Table 1). Among the invasive isolates, 19 (12%)
were resistant to erythromycin, while the isolates asso-
ciated with pharyngitis presented significantly higher
macrolide resistance – 21% (P = 0.016, two-tailed Fisher’s
exact test). Among the invasivemacrolide-resistant isolates, 10
(53%) presented the M phenotype and were therefore
susceptible to clindamycin, whereas the remaining nine
(47%) were also constitutively resistant to clindamycin
(cMLSB phenotype). The proportion of the two pheno-
types was similar among the pharyngitis isolates, with
37 isolates (55%) presenting the M phenotype and 30
(45%) presenting the MLSB phenotype (one with indu-
cible resistance and the others with constitutive
Table 1 PFGE clusters presenting antimicrobial resistant
isolates collected from invasive infections and
pharyngitis in Portugal





G27 M 6 19
M,Tet 1
H26 MLSB,Bac 6 17
Tet 1
I24 MLSB,Tet 1
J16 Tet 12 1
K14 M 1
L13 MLSB,Tet 1 6
Tet 2
M11 MLSB,Tet 1
N10 Tet 1 1
MLSB,Tet 1
O9 M 4 5
R6 M 3
S6 M 1
a Clusters are designated by capital letters and a subscript number indicating
the number of isolates in each cluster;
b The antibiotics tested were penicillin quinupristin/dalfopristin,
chloramphenicol, vancomycin, linezolid, levofloxacin, erythromycin,
clindamycin, tetracycline, and bacitracin. M, presenting the M phenotype of
macrolide resistance; MLSB, presenting the MLSB phenotype of macrolide
resistance; Tet, non-susceptibility to tetracycline; M,Tet, presenting the M
phenotype of macrolide resistance and resistance to tetracycline; MLSB,Tet,
presenting the MLSB phenotype of macrolide resistance and resistance to
tetracycline; MLSB,Bac, presenting the MLSB phenotype of macrolide resistance
and resistance to bacitracin.
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the M phenotype of macrolide resistance carried only
the mef(A) variant of the mef determinant. The cMLSB
isolates carried only the erm(B) gene, except for one
pharyngitis isolate which also harbored mef(A), and the
only iMLSB isolate in the collection that presented the
erm(A) gene.
In contrast to erythromycin, tetracycline resistance was
much lower among the pharyngitis isolates when com-
pared with the invasive group (6% vs 17%, P < 0.001).
One invasive isolate presented intermediate resistance to
tetracycline (MIC = 3μg/ml). All the resistant strains car-
ried the tet(M) gene, except one pharyngitis isolate for
which no PCR product was obtained for any of the
screened tetracycline-resistance genes. The tet(L) gene
was detected in only one pharyngitis isolate, which also
harbored tet(M), while the genes tet(K) and tet(O) were
not amplified in any of the studied isolates. Overall there
was a positive association between the genes tet(M) and
erm(B) (P < 0.001), but that association was not observedamong the subset of invasive isolates, since only three of
the 27 tet(M)-positive invasive isolates also carried the
erm(B) gene (P = 0.178).
Bacitracin resistance was detected in a total of 23 iso-
lates (5%), with no significant differences among the two
types of infection considered. All these isolates expressed
the cMLSB phenotype of macrolide resistance and were
tetracycline-susceptible.
Characterization of GAS clones
Globally, among the 480 isolates there were 36 emm
types, 17 T types, and 49 SAg profiles (the genes
included in each SAg profile are presented in Additional
file 1). In the subset of 170 isolates (100 from pharyngitis
and 70 from invasive infections) selected for MLST ana-
lysis, 49 different STs were identified. Nineteen PFGE
clusters (groups of > 5 isolates presenting ≥ 80% similar-
ity on the PFGE profile) were obtained including 268
pharyngitis isolates and 143 invasive isolates (86% of all
isolates) (Table 2 and Table 3). Except for R6, isolates
grouped into PFGE clusters presented some variability
in their emm type, ST, T type, or SAg profile, with most
variability found in the later two properties. Still, in most
PFGE clusters the majority of the isolates were charac-
terized by a single profile of dominant properties. The
emm diversity among the PFGE clusters differed signifi-
cantly (Table 4). Within each PFGE cluster, different
emm types were associated with distinct SAg profiles
(Table 2 and Table 3), although globally the emm and
PFGE had a similar predictive power over the SAg pro-
file (data not shown).
Unrelated STs within the same PFGE clusters were
associated with isolates of different emm types, while
isolates of the same emm type presented the same ST or
single-locus variants (SLVs) (Table 2 and Table 3). The
only exceptions were ST39 and ST561 that were both
associated with cluster G27 and emm4, but were double-
locus variants (DLVs) of each other. In clone I24, four
distinct STs were found. While ST25 and ST554 were
SLVs and were both associated with emm44/61, ST150
belonged to a different clonal complex, but was also
associated with a different emm type (emm75). Finally,
ST555 despite being associated with an isolate of a dif-
ferent emm type (emm89) is a SLV of ST25, which may
explain why this isolate was clustered in I24 and not in
the major PFGE cluster associated with this emm type
(C38).
Isolates expressing the M phenotype of macrolide re-
sistance belonged mostly to clusters G27, O9, and R6,
while the majority of MLSB isolates were clustered in
H26 and L13 (Table 1). Isolates belonging to emm types
1, 4, and 28 were separated into different PFGE clusters
according to macrolide resistance (B49 and O9 for
emm1; F29 and G27 for emm4; H26 and M11 for emm28,











(no. of isolates)Invasive Pharyngitis
A51 3 15 (9.4) 36 (11.25) 3 (22), NT (14), 3/13 (13), 1 (2) 8 (48), 37 (2), 2 (1) 406 (8), 15 (4), 315 (2)
B49 1 28 (17.5) 20 (6.3) 1 (46), NT (2) 10 (47), 3 (1) 28 (10)
stIL103 1 (0.6) 0 1 (1) 10 (1) 28 (1)
C38 89 12 (7.5) 25 (7.8) B3264 (37) 27 (21), 29 (8), 46 (5), 43 (2), 40 (1) 408 (5), 553 (1), 101 (2)
75 0 1 (0.3) 25 (1) 42 (1) 150 (1)
D36 12 10 (6.3) 25 (7.8) 12 (29), NT (6) 33 (29), 16 (5), 46 (1) 36 (13), 551 (2)
94 1 (0.6) 0 B3264 (1) 35 (1) 89 (1)
E30 6 11 (6.9) 19 (5.9) 6 (27), NT (2), 2(1) 2 (28), 5 (1), 9 (1) 382 (6), 411 (3)
F29 4 1 (0.6) 28 (8.8) 4 (29) 23 (27), 22 (2) 39 (5)
G27 4 8 (5.0) 19 (5.9) 4 (23), B3264 (2), 2/27/44 (1), 2/4 (1) 23 (23), 30 (2), 40 (1), 41 (1) 39 (8), 561 (1)
H26 28 7 (4.4) 17 (5.3) 28 (23), NT (1) 27 (13), 24 (10), 15 (1) 52 (10)
22 0 1 (0.3) 12 (1) 3 (1) nd
75 0 1 (0.3) NT (1) 7 (1) 481 (1)
I24 44/61 6 (3.8) 16 (5.0) 2/27/44 (19), NT (2), 12 (1) 32 (16), 12 (6) 25 (5), 554 (1)
75 0 1 (0.3) 25 (1) 36 (1) 150 (1)
89 0 1 (0.3) 5/27/44 (1) 6 (1) 555 (1)
J16 64 11 (6.9) 0 3/13 (5), NT (4), 1 (2) 46 (10), 43 (1) 164 (4), 124 (1)
53 2 (1.3) 0 NT (2) 26 (2) 11 (1)
74 0 1 (0.3) B3264 (1) 11 (1) 120 (1)
87 0 1 (0.3) 28 (1) 38 (1) 62 (1)
89 0 1 (0.3) B3264 (1) 43 (1) 568 (1)
a Clusters are designated by capital letters and a subscript number indicating the number of isolates in each cluster; b NT, non-typeable; c nd, not determined.
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ST, and SAg profile) of each pair of PFGE clusters were
the same.
Bacitracin-resistant isolates were all clustered in PFGE
H26 and were characterized as emm28-T28, except for
one isolate that was emm22-T12. However, this cluster
was not restricted to bacitracin-resistant isolates, since it
also included three bacitracin susceptible isolates, two of
which were also emm28-T28, while the other was
emm75 but T non-typable.Surface antigen differences between invasive and
pharyngitis isolates
The invasive isolates were significantly less diverse than
the pharyngitis isolates by T typing and SAg profiling
(Table 5). However, while the emm type distribution
varied between the invasive and pharyngitis isolates
(P < 0.001) no differences were noted in the T types. Six-
teen emm types occurred only in invasive infection or pha-
ryngitis, but in most cases the small number of isolates
associated with these emm types prevented the differ-
ences from reaching statistical significance (Figure 1). In
contrast, the overrepresentation of emm types 1, 4, 64,
and 75 in one of the groups was statistically supported.SAg differences between invasive and pharyngitis isolates
A detailed analysis of the SAg profiling results of the iso-
lates is performed elsewhere [18]. Briefly, the chromoso-
mally encoded SAg genes smeZ and speG were the most
frequent among the 480 isolates (n = 461 and 417, re-
spectively), followed by speC (n = 247), ssa (n = 170),
speJ (n = 157), speA (n = 154), speK (n = 118), speH
(n = 82), speI (n = 73), and speL and speM, which were
always detected together (n = 44). The association of
individual SAg genes with disease presentation was
tested. In the analysis of these results, the SAg genes
speG and smeZ were not considered because they were
present in nearly all isolates, and the genes speL and
speM were considered as a single entity, since they
always co-occurred. Individually, the genes speA and speJ
were both associated with invasive isolates (P < 0.001).
As expected, strains carrying both these genes were also
associated with invasive infections (P < 0.001), but no
synergistic effect between the two genes was observed,
since the presence of one did not significantly increase
the representation of the other among invasive isolates.
In contrast, speC (P = 0.002), ssa (P < 0.001), and speL/M
(P < 0.001) were individually associated with pharyn-
gitis. The combinations speC+speL/M and ssa+speL/M
were both associated with pharyngitis (P = 0.004 and















K14 2 1 (0.6) 13 (4.1) 2 (13), 4 (1) 31 (12), 48 (2) 55 (5)
L13 22 1 (0.6) 7 (2.2) 12 (8) 21 (6), 13 (1), 19 (1) 46 (2), 389 (1)
9 1 (0.6) 1 (0.3) 9 (1), NT (1) 46 (2) 75 (2)
2 0 1 (0.3) 2 (1) 31 (1) 55 (1)
74 1 (0.6) 0 9 (1) 5 (1) 120 (1)
st106M 1 (0.6) 0 4 (1) 49 (1) 53 (1)
M11 28 8 (5.0) 3 (0.9) 28 (11) 24 (7), 27 (3), 15 (1) 52 (5)
N10 87 2 (1.3) 7 (2.2) 28 (8), 6 (1) 20 (3), 27 (3), 2 (1), 18 (1), 44 (1) 62(2)
22 0 1 (0.3) 12 (1) 21 (1) 46 (1)
O9 1 4 (2.5) 5 (1.6) 1 (8), 13 (1) 10 (9) 28 (4)
P8 78 4 (2.5) 4 (1.3) 11 (7), 3/13 (1) 29 (8) 409 (3)
Q8 43 4 (2.5) 0 3/13 (2), NT (2) 11 (4) 3 (2)
58 2 (1.3) 2 (0.6) NT (4) 17 (3), 14 (1) 410 (3), 176 (1)
R6 75 0 6 (1.9) 25 (6) 39 (6) 150 (2)
S6 9 1 (0.6) 4 (1.3) 9 (5) 40 (5) 75 (2)
12 0 1 (0.3) 12 (1) 33 (1) 36 (1)
a Clusters are designated by capital letters and a subscript number indicating the number of isolates in each cluster; b NT, non-typeable.
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effect relative to the presence of a single gene. How-
ever, the association of speC with pharyngitis isolates
can be explained by a high frequency of co-occurrence
of this gene with ssa, since the isolates harboring speC
without ssa were not significantly associated with any
of the groups. An interesting situation occurred when
analyzing the interaction between speJ (associated with
invasive infections) and ssa (associated with pharyn-
gitis). Among isolates carrying speJ, the group that also
carried ssa was no longer associated with invasive
infections, while the association of isolates carrying ssa
with pharyngitis was not significantly altered by theTable 4 Simpson’s index of diversity and 95% Confidence
intervals (CI95%) of emm types for each PFGE cluster
PFGE clustera No. emm types SID [CI95%]
B49 2 0.041 [0–0.118]
C38 2 0.053 [0–0.151]
D36 2 0.056 [0–0.159]
H26 3 0.151 [0–0.336]
I24 3 0.163 [0–0.361]
J16 5 0.533 [0.255-0.812]
L13 5 0.628 [0.353-0.903]
N10 2 0.200 [0–0.504]
Q8 2 0.571 [0.571-0.571]
S6 2 0.333 [0–0.739]
a PFGE clusters A51, E30, F29, G27, K14, M11, O9, P8, and R6 include only one emm
type (SID=0).presence of speJ. This argues for a dominant effect of
the presence of ssa over that of speJ in determining
the invasive capacity of individual isolates. The associ-
ation of SAg profiles with disease presentation was
also tested. Two SAg profiles presented a significant as-
sociation with invasive isolates, namely SAg10 (speA
+speG+speJ+smeZ+) and SAg46 (speG+smeZ+) (P < 0.001).
The remaining profiles were not significantly associated
with any of the two groups of isolates.
When the same kind of analysis was performed for
emm types and individual SAg genes, three combina-
tions with statistical significance emerged: the associ-
ation of isolates presenting emm1 and speA, and emm1
and speJ with invasive infections (P < 0.001), and the as-
sociation of isolates carrying emm75 and speL/M with
pharyngitis (P = 0.001). In all cases, no synergistic or an-
tagonistic interaction was detected between emm type
and SAg gene, since the emm type did not alter the asso-
ciation of the SAg gene with a particular group of
isolates.
Differences between the PFGE clusters found among
invasive infection and pharyngitis
The associations described above can be correlated
with the PFGE clusters which were also different be-
tween the invasive and pharyngitis groups of isolates
(P < 0.001), in agreement with the differences found in
emm types (Figure 1 and Figure 2). All the 19 major PFGE
clusters occurred in both invasive and pharyngitis iso-
lates, except for R6 (emm75-T25-ST150-SAg39), which
Table 5 Simpson’s index of diversity and 95% Confidence intervals (CI95%) of the typing methods used in the analysis
of the 160 invasive isolates and 320 pharyngitis isolates
Typing method Invasive Pharyngitis
No. types SID [CI95%] No. types SID [CI95%]
T typing 13 0.882 [0.859-0.904] 17 0.915 [0.907-0.923]
emm typing 30 0.920 [0.900-0.940] 26 0.921 [0.911-0.931]
PFGE profiling 30 0.930 [0.912-0.947] 44 0.947 [0.939-0.954]
SAg profiling 27 0.911 [0.891-0.931] 46 0.941 [0.932-0.951]
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difference did not reach statistical significance due to
the small number of isolates in this cluster. PFGE dis-
tinguished several groups of isolates belonging to emm
types 1 and 4. The difference in the distribution be-
tween pharyngitis and invasive infection was not found
for all PFGE clusters containing isolates carrying each
of these two emm types, but only for those including
macrolide-susceptible isolates (B49 associated with inva-
sive infections and F29 associated with pharyngitis, re-
spectively, P < 0.001). The emm1 and emm4 isolates
expressing macrolide resistance (M phenotype) were
grouped into PFGE clusters O9 and G27, respectively,
which presented a similar prevalence among invasive
infections and pharyngitis (Figure 2). PFGE J16, which
included all emm64 isolates, was also associated with
invasive infections (P < 0.001). The emm75 association
with pharyngitis was not translated into an association
of a specific PFGE cluster, since the 19 emm75 strains
were scattered into various PFGE clusters (Table 2 and
Table 3).
Not surprisingly, three emm-PFGE cluster combina-
tions showed significant associations with infection type:
emm1-B49 and emm64-J16 were associated with invasive
















Figure 1 Distribution of emm types among 160 invasive isolates and
isolates - emm18 (n=4), 25 (n=1), 29 (n=2), 30 (n=1), 43 (n=4), 48 (n=1), 53
(n=1), 113 (n=3), 114 (n=1), 118 (n=1), st106M (n=1), stG1750 (n=1), stIL103(P < 0.001). It was not possible to detect any synergistic or
antagonistic interaction between PFGE and emm type in
modulating the association of the isolates with either
group. The same was true for the statistically significant
combinations between PFGE clusters and individual SAg
genes, namely the combination of B49 with speA and with
speJ (both associated with invasive infections, P < 0.001),
and the combination of F29 with speC and with ssa (both
associated with pharyngitis, P < 0.001).
Discussion
Several studies yielding conflicting results have attempted
to compare the clonal composition of GAS populations
causing invasive and non-invasive infections in order to
identify particularly virulent clones or properties that may
be used as epidemiological markers of invasiveness
[7,8,11,12,16]. However, many of those studies were li-
mited in the size and diversity of the GAS collections
studied or in the typing methodologies used, with most of
them relying essentially on emm typing, which has been
shown to be insufficient for the complete identification of
GAS clones [13]. In this work, we used several different
typing methods to compare a collection of genetically
diverse GAS isolates recovered from normally sterile sites
during a period of six years in Portugal [17] with isolates22 28
44
/6









320 pharyngitis isolates. Other includes emm types identified in ≤ 5
(n=3), 58 (n=5), 74 (n=2), 77 (n=4), 90 (n=1), 94 (n=3), 102 (n=3), 103


















A51 B49 C38 D36 E30 F29 G27 H26 I24 J16 K14 L13 M11 N10 O9 P8 Q8 R6 S6
Figure 2 PFGE clusters found among 160 invasive isolates and 320 pharyngitis isolates. Approximately 11% of invasive and 16% of non-
invasive isolates were included in PFGE clusters of ≤ 5 isolates that are not represented. The asterisk indicates significant differences (P<0.001).
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with tonsillo-pharyngitis, during the same time period and
in the same geographical region. The nasopharyngeal mu-
cosa has been suggested to be the main reservoir for GAS
isolates associated with invasive infections [19,20].
The differences among the GAS clones associated with
invasive infections and pharyngitis were reflected in anti-
microbial resistance, with the invasive group of isolates
presenting lower macrolide resistance and higher tetra-
cycline resistance, when compared with the pharyngitis
group. Among isolates belonging to the same emm
types, namely emm1 and emm4, only the macrolide-
susceptible clones were associated with either invasive
infections or pharyngitis. The macrolide-resistant clones
of these emm types are reflected in invasive infections
according to their prevalence in pharyngitis, suggesting
that these are translating more the antibiotic selective
pressure than the invasive capacity of the clones. Tetra-
cycline is not currently used in the treatment of GAS
infections but resistance to this antimicrobial in S. pyo-
genes is usually acquired by horizontal transfer, since the
resistance genes are frequently encoded in mobile gen-
etic elements with a wide host range [21]. These ele-
ments often carry macrolide resistance genes as well,
and in S. pyogenes a significant association between the
presence of the genes erm(B) and tet(M) has been
reported and it has been suggested that tetracycline use
could contribute to the selection of macrolide-resistant
GAS isolates [21,22]. In our study, the association be-
tween the presence of the genes erm(B) and tet(M) was
observed globally, but not among the invasive isolates,
suggesting that the genetic elements carrying tetracyc-
line resistance conferring genes may be different be-
tween the two bacterial populations.
Bacitracin susceptibility is routinely used for the pre-
sumptive identification of GAS, although resistant clones
have been identified in several countries [23-25]. In ourGAS collection, all the bacitracin-resistant isolates (5%),
regardless of the type of infection, were clustered in the
same PFGE clone (H26) and belonged to ST52, although
one was emm22-T12 while the others were all emm28-T28.
Isolates with such characteristics had been previously
reported in Portugal associated with tonsillo-pharyngitis,
skin infections and asymptomatic carriage [26,27], but
not with invasive infections. Bacitracin resistance among
invasive isolates has been previously reported only
among isolates recovered in France and in San Francisco
[24,25].
Although 74% of the invasive isolates in our collection
belonged to clones which were equally frequent among
pharyngitis, suggesting that a significant part of the
invasive GAS population mirrors the clonal structure
of the circulating GAS isolates, the remaining isolates
represented clones that had an enhanced capacity to
cause invasive disease. We also found significant associa-
tions between individual properties or pairwise combina-
tions of properties and disease presentation. Since in
most cases these were also characteristics of the more
invasive clones, we cannot exclude that the associations
of individual properties or pairwise combinations of
properties can reflect, at least partially, the distribution
of genetic lineages in the two GAS populations analyzed.
Individually, emm types 1 and 64 were associated with
invasive infections. Isolates belonging to these emm
types presented the only two SAg profiles significantly
associated with invasive infections. Surprisingly, only
one of these SAg profiles includes a phage-encoded SAg
gene (speA). In agreement with our observation, a previ-
ous study found that within the same PFGE-emm group,
the SAg profiles significantly associated with invasive
infections had a smaller number of SAg genes than the
dominant profiles in pharyngitis [28]. These results sug-
gest that although some SAg genes may significantly
contribute to the virulence of S. pyogenes, the rise and
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upon the acquisition of phage-encoded SAg genes. Still,
in our study, the SAg genes speA and speJ were both sig-
nificantly more prevalent among invasive isolates. This
association was not substantially affected by emm type,
PFGE clone, nor by the presence of other SAg genes,
suggesting that speA and speJ can be regarded by them-
selves as markers for invasiveness. Although such associ-
ation has not been previously noted for speJ, the speA gene
has been frequently associated with invasive infections
[6,8,16] and the production of SpeA by GAS isolates has
been linked to streptococcal toxic shock syndrome [29].
On the other hand, we identified an association of
pharyngitis isolates with emm types 4 and 75, and with
the SAg genes speC, ssa, and speL/M. The association of
speC with non-invasive infections has been previously
reported [6,16,30], but in our collection this association
could be explained simply by a high frequency of co-
occurrence of this gene with ssa which was strongly asso-
ciated with pharyngitis, as was also noted in a recent study
[16]. The presence of the genes speL and speM was not
previously associated with non-invasive infections.
Since there is a strong correlation of the SAg profile
with emm type and of both these properties with PFGE
type, some of these individual factors frequently co-
occurred in the same clones. Therefore, combinations of
these characteristics were also significantly associated
with disease presentation. However, we could not detect
any synergistic or antagonistic interactions between most
of these characteristics, meaning that their co-occurrence
in a particular isolate does not make it more invasive than
isolates sharing only one of these characteristics.
Two PFGE clusters were significantly more prevalent
among isolates associated with invasive disease than
among those causing tonsillo-pharyngitis. One of these
was a cluster of macrolide-susceptible isolates character-
ized as emm1-T1-ST28 and by the presence of the SAg
genes speA, speG, speJ, and smeZ (B49), which accounted
for 18% of the invasive isolates. M1T1 isolates have been
frequently associated with severe invasive GAS disease,
and the acquisition of prophage-encoded virulence
genes, as well as horizontal gene transfer events by hom-
ologous recombination were implicated in the increased
virulence of these isolates [31,32]. However, many epi-
demiological studies found a similar prevalence of this
clone among invasive and non-invasive isolates [10-12],
questioning its enhanced invasive capacity. In contrast
to these findings, but similarly to those of others [6-9],
we found an association between this clone and invasive
GAS disease in Portugal, although it can also frequently
cause milder infections such as pharyngitis (it accounted
for 6% of the pharyngitis isolates analyzed in this study).
The other cluster significantly associated with invasive
infections in Portugal was J16, which was dominated byisolates belonging to emm64-ST164 and carrying the
SAg genes speG and smeZ. A clone with these character-
istics has not been previously associated with invasive
disease and emm64 has been infrequently reported
among invasive GAS isolates [4,33,34]. The higher inva-
sive capacity of this clone cannot be attributed to its
SAg repertoire, since these isolates do not harbor any of
the SAg genes associated with invasive infection. Other,
still unidentified, characteristics may be responsible for
the properties of this clone.
In contrast to these PFGE clones, the F29 clone of
macrolide-susceptible isolates characterized by emm4-
T4-ST39 and harboring the genes speC, ssa and smeZ
was associated with pharyngitis, suggesting that this
clone may have a reduced ability to cause invasive dis-
ease, in agreement with the negative association between
emm4 and invasive infection that has been suggested
elsewhere [16]. The association of emm75 with pharyn-
gitis has not been previously reported and was not trans-
lated into particular PFGE clusters due to the high
diversity of emm75 isolates.
Our data confirms that the widely dispersed M1T1
clone has enhanced invasiveness but we also identified
clones with increased or decreased invasive capacity that
may have emerged locally and that have a more limited
temporal and geographical spread. The emm alleles and
the SAg genes characteristic of these clones were asso-
ciated with particular disease presentations. Other indi-
vidual emm alleles and SAg genes were also associated
with a higher propensity to cause invasive infections or
pharyngitis indicating the importance of these character-
istics in determining an isolate’s invasive capacity.
Other factors that were not evaluated in this study
may contribute to a different distribution of GAS clones
in less severe and more severe infections. These include
bacterial factors, such as the occurrence of mutations in
transcriptional regulators controlling the expression of
virulence factors, which seems to play an important role
in the pathogenesis of some GAS isolates [35]. For other
clones, the ability to cause invasive infections may be
more dependent on exploiting host factors, like the HLA
class II haplotype [36], which may vary in frequency in
different human populations.
Conclusions
This study established links between particular genetic
lineages and the type of infection, indicating that genetic
characteristics of the bacteria play an important role in
determining the outcome of their interaction with the
human host. The different distribution of clones in the
two types of infection supports the relevance of PFGE as
a typing methodology for GAS [13]. This was further
evidenced by the fact that the macrolide-resistant emm1
and emm4 PFGE clones were not associated with any
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tible clones carrying the same emm types that were
associated with invasive infections and pharyngitis, res-
pectively. Moreover, in contrast to other reports
[12,15] we found associations between particular emm
alleles and SAg genes and disease presentation. In this
study, we identified emm4, emm75, ssa and speL/M as
independent markers for pharyngitis and emm1,
emm64, speA, and speJ as independent markers for
invasiveness. Our data re-enforces the multi-factorial
nature of GAS invasive capacity and highlighted
lineages and characteristics, in addition to the well
known M1T1 lineage, that are associated with particu-
lar disease presentations and that may further increase
in importance.Methods
Bacterial isolates
The invasive isolates (n = 160) were collected from nor-
mally sterile sites, and their partial characterization was
previously reported [17]. A total of 320 non-duplicate
GAS isolates were randomly selected among a collec-
tion of 1604 isolates recovered from pharyngeal exu-
dates of patients presenting with tonsillo-pharyngitis in
32 laboratories distributed throughout Portugal, be-
tween 2000 and 2005, in the proportion of 1:2 (inva-
sive:pharyngitis) for each studied year. These isolates
were recovered from pediatric patients (<18 yrs) and
showed a balanced distribution by gender. The subset
of macrolide-resistant pharyngeal isolates had been par-
tially characterized [27,37]. Strains were identified by the
submitting laboratories and confirmed in our labora-
tory by colony morphology, β-hemolysis and the pres-
ence of the characteristic group antigen (Slidex Strepto A,
BioMérieux, Marcy l’Etoile, France).Antimicrobial susceptibility testing
Susceptibility tests were performed by disk diffusion on
Mueller-Hinton agar supplemented with 5% defibrinated
sheep blood, according to the guidelines of the Clinical
and Laboratory Standards Institute (CLSI) using the fol-
lowing antibiotic disks (Oxoid, Basingstoke, UK): penicil-
lin, vancomycin, erythromycin, tetracycline, levofloxacin,
chloramphenicol, clindamycin, quinupristin/dalfopristin,
and linezolid. Whenever isolates with intermediate sus-
ceptibility were identified, the results were confirmed by
MIC determination using E-test strips (BioMérieux,
Marcy l’Etoile, France). The macrolide resistance pheno-
type was determined as previously described [38]. Sus-
ceptibility to bacitracin was determined for all isolates
using disks containing 0.05 U of bacitracin (Oxoid,
Basingstoke, UK), as described elsewhere [27].Detection of antimicrobial resistance genetic
determinants
Bacterial DNA was prepared according to the protocols
of the Centers for Disease Control and Prevention
(CDC) [39]. Determination of the macrolide resistance
genotype was performed for strains presenting either the
M or the MLSB macrolide resistance phenotype, by a
multiplex PCR reaction with primers to detect the erm
(B), erm(A) and mef genes, as previously described [40].
Isolates carrying the mef gene were subjected to a sec-
ond PCR reaction in order to discriminate between mef
(A) and mef(E) [37]. Tetracycline resistant isolates were
PCR-screened for the presence of the genes tet(K), tet
(L), tet(M), and tet(O) as previously described [41].
Strains harboring each of the resistance genes were used
as positive controls for the PCR reactions.
T-typing
Strains were cultured in Todd-Hewitt broth (Oxoid,
Basingstoke, UK) at 30°C overnight and treated with
swine pancreatic extract, using the Auxiliary Reagents
for Hemolytic Streptococcus Typing (Denka Seiken,
Tokyo, Japan), and following the manufacturer’s instruc-
tions. T serotypes were determined by slide agglutination
with 5 polyvalent and 19 monovalent sera (Hemolytic
Streptococcus Group-A Typing Sera, Denka Seiken).
emm-typing and SAg gene profiling
The emm-typing of all isolates was performed according
to the protocols and recommendations of the CDC, and
the first 240 bases of each sequence were searched
against the emm CDC database [39]. Identity of ≥ 95%
with previously described sequences over the 150 bases
considered allowed the assignment of an emm type. The
presence of the SAg genes speA, speC, speG, speH, speI,
speJ, speK, speL, speM, smeZ, and ssa, and of the chro-
mosomally encoded exotoxin genes speB and speF (used
as positive control fragments) was assessed in all 160 in-
vasive and 320 non-invasive GAS isolates by two multi-
plex PCR reactions as described elsewhere [18].
PFGE macrorestriction profiling and MLST
Agarose plugs of bacterial DNA were prepared as previ-
ously described [27]. After digestion with SmaI or Cfr9I
(Fermentas, Vilnius, Lithuania), the fragments were
resolved by PFGE [27]. The isoschizomer Cfr9I was used
only for the isolates with the M phenotype, which were
not digested by SmaI [13,27]. The macrorestriction pat-
terns generated were compared using the Bionumerics
software (Applied Maths, Sint-Martens-Latem, Belgium)
to create UPGMA (unweighted pair group method with
arithmetic mean) dendrograms. The Dice similarity coef-
ficient was used, with optimization and position toler-
ance settings of 1.0 and 1.5, respectively. PFGE clones
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with ≥ 80% relatedness on the dendrogram [13]. MLST
analysis was performed as described elsewhere [42] for
representatives of each PFGE cluster (a total of 100 non-
invasive and 70 invasive isolates). When more than one
emm or T-type was present in the same PFGE cluster,
isolates expressing different surface antigens were
selected. Allele and sequence type (ST) identification
was performed using the S. pyogenes MLST database
[43]. Whenever new alleles were identified, chromato-
grams of both strands were submitted to the database
curator for approval and an allele number was assigned.
Clonal complexes were determined using the goeBURST
algorithm implemented in PHYLOViZ [44].
Statistical analysis
The diversities of the different PFGE clusters were com-
pared using the Simpson’s index of diversity (SID) with
corresponding 95% confidence intervals (CI95%) [13].
Differences in antibiotic resistance between the invasive
and non-invasive groups of isolates were evaluated using
Fisher’s exact test. P values < 0.05 were considered to in-
dicate statistical significance. SAg genes, emm types and
PFGE types were screened for associations with the inva-
sive group by computing an odds-ratio and an associated
Fisher’s exact test. Additionally, pairs of individual SAg
genes with each other or with emm types or PFGE types
were similarly tested for the association of each pairs’
co-occurrence with the invasive group of isolates. For
the pairs where at least one of the types individually or
their co-occurrence were associated (either positively or
negatively) with the invasive group, two more tests were
done, to investigate if the association of one of the types
individually was modified by the co-occurrence of the
other type in the pair (synergism or antagonism). Con-
sidering a pair of types A and B, this test compares the
proportion of invasive isolates among the ones that have
A type but not B with the same proportion among iso-
lates that have both A and B types. If the proportions
are statistically different, according to a Fisher’s exact
test, we can conclude that type B modifies the associ-
ation of type A with the invasive group of isolates. Con-
versely, if the proportion of invasive isolates among the
ones that have the B type but not A differs from the
same proportion among isolates that have both A and B
types, type A modifies the association of type B with the
invasive group. If the isolates that are simultaneously of
the A and B type show a significantly stronger associ-
ation with invasive infection than the one observed for
isolates having either the A or B type, the types are said
to be synergistic. If, on the other hand, isolates that are
simultaneously of the A and B type show a significantly
weaker association with invasive infection than the one
observed for isolates having either the A or B type, thetypes are said to be antagonistic. All the p-values
obtained in each step of the screening procedure were
corrected for multiple testing through the False Discov-
ery Rate (FDR) linear procedure [45].Additional file
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